Santiago Arroyo, M.D., Ph.D.

Santiago Arroyo, M.D., Ph.D.

Chief Development OfficeratBicycle Therapeutics· In proxies 2023–2024

Pay in FY2024-3% from the year before · Bicycle Therapeutics stock -22.6% the same year

Santiago Arroyo, M.D., Ph.D. was paid $2.6M in FY2024 (Dec), down 3%. Bicycle Therapeutics stock fell 22.6% that year.

Pay$100 in the stock at the end of FY22 → $47
Pay is from the Summary Compensation Table of each Bicycle Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Bicycle TherapeuticsPublic company · 3 yr
    • Chief Development Officer2023 – Present · 3 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?